Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 2
Two Onc Docs
00:00
The Transformative Impact of CAR-T Therapies in Multiple Myeloma
This chapter explores the groundbreaking role of CAR-T therapies in treating multiple myeloma, featuring FDA-approved drugs Idacel and Siltacel. It highlights their innovative use of engineered T-cells to target BCMA, demonstrating significant efficacy for heavily pretreated patients and the stringent approval processes these therapies undergo.
Transcript
Play full episode
